Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Windisch

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|November 8, 2011
Synthesis of monomeric derivatives to probe memoquin's bivalent interactionsMaria Laura Bolognesi, GianPaolo Chiriano, Manuela Bartolini, et al.
Neuron|October 12, 2004
The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's diseaseBirgit Hutter-Paier, Henri J Huttunen, Luigi Puglielli, et al.
Psychopharmacology|November 26, 2016
Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humansJan Laczó, Hana Markova, Veronika Lobellova, et al.
Plos One|March 18, 2014
Tracking of magnetite labeled nanoparticles in the rat brain using MRINaira P Martínez Vera, Reinhold Schmidt, Klaus Langer, et al.
Journal of Alzheimer'S Disease : JAD|September 28, 2013
Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosisPaolo Paganetti, Katia Antoniello, Kavi Devraj, et al.
Alzheimer'S Research & Therapy|November 28, 2013
Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood-brain barrier modelSabrina Meister, Iavor Zlatev, Julia Stab, et al.
International Clinical Psychopharmacology|August 16, 2003
Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory studyX Antón Alvarez, Carolina Sampedro, Paula Pérez, et al.
Plos One|July 7, 2018
BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brainsMirsada Causevic, Kristina Dominko, Martina Malnar, et al.
Nature Medicine|October 7, 2008
Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathologyStephan Schilling, Ulrike Zeitschel, Torsten Hoffmann, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 18, 2021
Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think TankMichael P Vitek, Joseph A Araujo, Michael Fossel, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|November 8, 2011
Synthesis of monomeric derivatives to probe memoquin's bivalent interactionsMaria Laura Bolognesi, GianPaolo Chiriano, Manuela Bartolini, et al.
Neuron|October 12, 2004
The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's diseaseBirgit Hutter-Paier, Henri J Huttunen, Luigi Puglielli, et al.
Psychopharmacology|November 26, 2016
Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humansJan Laczó, Hana Markova, Veronika Lobellova, et al.
Plos One|March 18, 2014
Tracking of magnetite labeled nanoparticles in the rat brain using MRINaira P Martínez Vera, Reinhold Schmidt, Klaus Langer, et al.
Journal of Alzheimer'S Disease : JAD|September 28, 2013
Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosisPaolo Paganetti, Katia Antoniello, Kavi Devraj, et al.
Alzheimer'S Research & Therapy|November 28, 2013
Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood-brain barrier modelSabrina Meister, Iavor Zlatev, Julia Stab, et al.
International Clinical Psychopharmacology|August 16, 2003
Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory studyX Antón Alvarez, Carolina Sampedro, Paula Pérez, et al.
Plos One|July 7, 2018
BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brainsMirsada Causevic, Kristina Dominko, Martina Malnar, et al.
Nature Medicine|October 7, 2008
Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathologyStephan Schilling, Ulrike Zeitschel, Torsten Hoffmann, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 18, 2021
Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think TankMichael P Vitek, Joseph A Araujo, Michael Fossel, et al.
Pageof 6